Marcio Souza
2021 - Praxis Precision Medicines
In 2021, Marcio Souza earned a total compensation of $10.9M as President and Chief Executive Officer at Praxis Precision Medicines, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $646,875 |
|---|---|
| Option Awards | $6,883,800 |
| Salary | $570,834 |
| Stock Awards | $2,773,584 |
| Other | $19,203 |
| Total | $10,894,296 |
Souza received $6.9M in option awards, accounting for 63% of the total pay in 2021.
Souza also received $646.9K in non-equity incentive plan, $570.8K in salary, $2.8M in stock awards and $19.2K in other compensation.
Rankings
In 2021, Marcio Souza's compensation ranked 911th out of 12,405 executives tracked by ExecPay. In other words, Souza earned more than 92.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 911 out of 12,405 | 93rd |
Division Manufacturing | 305 out of 5,494 | 94th |
Major group Chemicals And Allied Products | 103 out of 2,369 | 96th |
Industry group Drugs | 87 out of 2,090 | 96th |
Industry Pharmaceutical Preparations | 57 out of 1,537 | 96th |
Source: SEC filing on April 14, 2022.
Souza's colleagues
We found two more compensation records of executives who worked with Marcio Souza at Praxis Precision Medicines in 2021.
News
Praxis Precision Medicines CEO Marcio Souza's 2023 pay falls 65% to $2.1M
April 26, 2024
Praxis Precision Medicines CEO Marcio Souza's 2021 pay jumps 148% to $11M
April 14, 2022
PTC Therapeutics CEO Stuart Peltz's 2020 pay jumps 36% to $11M
April 29, 2021
PTC Therapeutics CEO Stuart Peltz's 2018 pay jumps 85% to $4M
April 25, 2019